WOLVERINE ASSET MANAGEMENT LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 163 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$193,000
-88.7%
4,135
-88.0%
0.00%
-88.9%
Q1 2017$1,713,000
-10.5%
34,600
+9.5%
0.03%
+8.0%
Q4 2016$1,915,000
+1277.7%
31,600
+1404.8%
0.02%
+1150.0%
Q3 2016$139,000
+25.2%
2,100
+5.0%
0.00%0.0%
Q2 2016$111,000
+5450.0%
2,000
+3900.0%
0.00%
Q1 2016$2,000
-99.7%
50
-89.0%
0.00%
-100.0%
Q3 2015$730,000
+900.0%
455
+97.0%
0.02%
+750.0%
Q2 2015$73,000
+2333.3%
231
+402.2%
0.00%
Q4 2013$3,000460.0%0.00%
Q3 2013$0460.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders